Market Closed -
Other stock markets
|
After market 04:28:49 pm | |||
76.17 USD | -2.46% | 76.23 | +0.08% |
05:15pm | Globe Life becomes target of second short seller this month | RE |
04:21pm | Wall St falls in lead up to Fed verdict after hot labor costs data | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 6.77 and 6.13 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.04% | 7.34B | B- | ||
+2.96% | 98.64B | B- | ||
+2.63% | 96.79B | B | ||
-15.06% | 81.97B | B+ | ||
+17.51% | 74.29B | D+ | ||
+8.49% | 31.45B | B | ||
+19.97% | 28B | B | ||
+6.64% | 27.72B | A | ||
+0.28% | 17.07B | C+ | ||
-9.75% | 14.82B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GL Stock
- Ratings Globe Life Inc.